Reply to B. Rimland's "Comments on 'Secretin and Autism: A Two-Part Clinical Investigation'"

The authors of a study (EC 625 006) of the clinical effects of the hormone secretin on autism respond to critical comments (EC 625 007) by defending their conclusion that secretin offers no observable clinical improvement in children with autism, their choice of methodology, and use of the Childhood...

Full description

Saved in:
Bibliographic Details
Published inJournal of autism and developmental disorders Vol. 30; no. 2; p. 97
Main Authors Chez, Michael G, Buchanan, Cathleen P
Format Journal Article
LanguageEnglish
Published 01.04.2000
Subjects
Autism
Drug Therapy
Outcomes of Treatment
Rating Scales
Research Methodology
Secretin
Online AccessGet full text

Cover

More Information
Summary:The authors of a study (EC 625 006) of the clinical effects of the hormone secretin on autism respond to critical comments (EC 625 007) by defending their conclusion that secretin offers no observable clinical improvement in children with autism, their choice of methodology, and use of the Childhood Autism Rating Scales. (Contains references.) (DB)
ISSN:0162-3257
DOI:10.1023/A:1005499220232